GlassScriptPhysician profile
David Andrew Saunders
NPI 1407837669
$885.53
in general payments reported to CMS, 2019-2025
21 companies · $223 in 2025
The $223 reported for 2025 was more than what a typical Radiation Oncology provider received nationally (typical 2025 total: $172).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $206 · 2021: $14.21 · 2022: $141 · 2023: $75.99 · 2024: $226 · 2025: $223.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $525.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $525.02 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Elekta, INC. | $163.90 | 2019-2025 | Elekta Unity |
| Boston Scientific Corporation | $126.93 | 2022-2024 | Spaceoar Vue System - 10ml |
| Novocure INC. | $86.96 | 2019 | |
| Astrazeneca Pharmaceuticals LP | $63.99 | 2025 | |
| Ge Healthcare | $43.63 | 2024 | |
| Siemens Medical Solutions USA, INC. | $38.92 | 2024 | Truebeam |
| Merck Sharp & Dohme LLC | $38.20 | 2022-2023 | Keytruda |
| Novartis Pharmaceuticals Corporation | $38.08 | 2025 | |
| E.R. Squibb & Sons, L.L.C. | $31.73 | 2021-2022 | |
| Seagen INC. | $29.90 | 2022-2023 | Padcev |
| Bayer Healthcare Pharmaceuticals INC. | $26.43 | 2022 | |
| Regeneron Healthcare Solutions, INC. | $26.11 | 2023 | Libtayo |
| Myriad Genetic Laboratories, INC. | $23.29 | 2025 | Prolaris |
| Eisai INC. | $22.92 | 2024 | |
| Pharmacyclics LLC, An Abbvie Company | $22.05 | 2023 | Imbruvica |
Show all 21 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbott Laboratories | $19.91 | 2022 | |
| Takeda Pharmaceuticals U.S.A., INC. | $19.86 | 2025 | Fruzaqla |
| Varian Medical Systems, INC. | $18.05 | 2019 | |
| Isoray, INC | $15.62 | 2022 | |
| Abbvie INC. | $14.91 | 2024 | |
| Biocompatibles, INC. | $14.14 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw David Saunders listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.